Global paclitaxel market was valued at 78.77 Million USD in 2017 and will reach 161.66 Million USD by the end of 2025, growing at a CAGR of 9.4% during 2019-2025. Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents. The report is revolving around Paclitaxel active pharmaceutical ingredients.
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it ""taxol"".
The classification of Paclitaxel includes Natural Paclitaxel API and Semi-synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 was about 31%, and the proportion was decreasing trend from 2012 to 2017.
Paclitaxel is widely sales for Ovarian Cancer, Cervical Cancer, Breast Cancer and Others. The most proportion of Paclitaxel was sales in Ovarian Cancer, and the consumption proportion was about 46% in 2017.
North America was the largest consumption place, with a consumption market share nearly 53% in 2017. Europe was the second largest consumption place with the consumption market share of 19%, China was also an important sales region for the Paclitaxel.
Market competition is intense. Phyton, ScinoPharm, Novasep, Samyang, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Paclitaxel for these regions, from 2012 to 2023 (forecast), covering China USA Europe Japan Korea India Southeast Asia South America
Global Paclitaxel market competition by top manufacturers/players, with Paclitaxel sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player.
The top players including Phyton ScinoPharm Novasep Samyang Polymed TAPI (Teva) Fresenius-kabi Huiang biopharma Southpharma Yunnan Hande Hainan Yew Pharm Jiangsu Yew Biotechnology
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Natural Paclitaxel API Semi-synthetic Paclitaxel API
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Paclitaxel for each application, including Ovarian Cancer Cervical Cancer Breast Cancer Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Paclitaxel Sales Market by Manufacturers, Regions, Type and Application, Forecast to 2026 1 Report Overview 1.1 Definition and Specification 1.2 Report Overview 1.2.1 Manufacturers Overview 1.2.2 Regions Overview 1.2.3 Type Overview 1.2.4 Application Overview 1.3 Industrial Chain 1.3.1 Paclitaxel Sales Overall Industrial Chain 1.3.2 Upstream 1.3.3 Downstream 1.4 Industry Situation 1.4.1 Industrial Policy 1.4.2 Product Preference 1.4.3 Economic/Political Environment 1.5 SWOT Analysis
2 Market Assessment by Type 2.1 PaclitaxelReprocessor Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020 2.2 PaclitaxelDrying & Storage Cabinets Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020 2.3 PaclitaxelTransport Systems Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020 2.4 Other Auxiliary Equipment Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Paclitaxel Sales Market Assessment by Type 3.1 Asia Pacific Market Performance (Sales, Revenue) 3.2 Key Players in Asia Pacific
4 North America Paclitaxel Sales Market Assessment by Type 4.1 North America Market Performance (Sales, Revenue) 4.2 Key Players in North America
5 Europe Paclitaxel Sales Market Assessment by Type 4.1 Europe Market Performance (Sales, Revenue) 4.2 Key Players in Europe
6 South America Paclitaxel Sales Market Assessment by Type 4.1 South America Market Performance (Sales, Revenue) 4.2 Key Players in South America
7 Middle Easr and Africa Paclitaxel Sales Market Assessment by Type 4.1 Middle Easr and Africa Market Performance (Sales, Revenue) 4.2 Key Players in Middle Easr and Africa 8 World Paclitaxel Sales Market Assessment by Type
8.1 Asia Pacific Paclitaxel Sales Market Assessment by Application (Consumption and Market Share) 8.2 North America Paclitaxel Sales Market Assessment by Application (Consumption and Market Share) 8.3 Europe Paclitaxel Sales Market Assessment by Application (Consumption and Market Share) 8.4 South America Paclitaxel Sales Market Assessment by Application (Consumption and Market Share) 8.5 Middle East and Africa Paclitaxel Sales Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis 9.1 Johnson & Johnson 9.1.1 Johnson & Johnson Profiles 9.1.2 Johnson & Johnson Product Portfolio 9.1.3 Johnson & Johnson Paclitaxel Sales Business Performance 9.1.4 Johnson & Johnson Paclitaxel Sales Business Development and Market Status 9.2 Cantel Medical 9.2.1 Cantel Medical Profiles 9.2.2 Cantel Medical Product Portfolio 9.2.3 Cantel Medical Paclitaxel Sales Business Performance 9.2.4 Cantel Medical Paclitaxel Sales Business Development and Market Status 9.3 Ecolab Inc 9.3.1 Ecolab Inc Profiles 9.3.2 Ecolab Inc Product Portfolio 9.3.3 Ecolab Inc Paclitaxel Sales Business Performance 9.3.4 Ecolab Inc Paclitaxel Sales Business Development and Market Status 9.4 Olympus 9.4.1 Olympus Profiles 9.4.2 Olympus Product Portfolio 9.4.3 Olympus Paclitaxel Sales Business Performance 9.4.4 Olympus Paclitaxel Sales Business Development and Market Status 9.5 Wassenburg Medical 9.5.1 Wassenburg Medical Profiles 9.5.2 Wassenburg Medical Product Portfolio 9.5.3 Wassenburg Medical Paclitaxel Sales Business Performance 9.5.4 Wassenburg Medical Paclitaxel Sales Business Development and Market Status 9.6 Custom Ultrasonics 9.6.1 Custom Ultrasonics Profiles 9.6.2 Custom Ultrasonics Product Portfolio 9.6.3 Custom Ultrasonics Paclitaxel Sales Business Performance 9.6.4 Custom Ultrasonics Paclitaxel Sales Business Development and Market Status 9.7 Steris 9.7.1 Steris Profiles 9.7.2 Steris Product Portfolio 9.7.3 Steris Paclitaxel Sales Business Performance 9.7.4 Steris Paclitaxel Sales Business Development and Market Status 9.8 Steelco 9.8.1 Steelco Profiles 9.8.2 Steelco Product Portfolio 9.8.3 Steelco Paclitaxel Sales Business Performance 9.8.4 Steelco Paclitaxel Sales Business Development and Market Status 9.9 Getinge 9.9.1 Getinge Profiles 9.9.2 Getinge Product Portfolio 9.9.3 Getinge Paclitaxel Sales Business Performance 9.9.4 Getinge Paclitaxel Sales Business Development and Market Status 9.10 Endo-Technik W. Griesat 9.10.1 Endo-Technik W. Griesat Profiles 9.10.2 Endo-Technik W. Griesat Product Portfolio 9.10.3 Endo-Technik W. Griesat Paclitaxel Sales Business Performance 9.10.4 Endo-Technik W. Griesat Paclitaxel Sales Business Development and Market Status 9.11 BES Rehab 9.12 ARC Healthcare Solutions 9.13 Belimed
10 World Paclitaxel Sales Market Assessment by Players 10.1 Global Paclitaxel Sales Sales (K Units) and Market Share by Players 2014-2020 10.2 Global Paclitaxel Sales Revenue (M USD) and Market Share by Players 2014-2020 10.3 Global Paclitaxel Sales Price (USD/Unit) of Players 2014-2020 10.4 Global Paclitaxel Sales Gross Margin of Players 2014-2020 10.5 Market Concentration
11 Regional Market Performance by Segment of Players 11.1 North America 11.1.1 North America Paclitaxel Sales Sales Assessment of Players 2014-2020 11.1.2 North America Paclitaxel Sales Revenue Assessment of Players 2014-2020 11.1.3 North America Paclitaxel Sales Price Assessment of Players 2014-2020 11.1.4 North America Paclitaxel Sales Gross Margin Assessment of Players 2014-2020 11.1.5 Market Concentration 11.2 Europe 11.2.1 Europe Paclitaxel Sales Sales Assessment of Players 2014-2020 11.2.2 Europe Paclitaxel Sales Revenue Assessment of Players of Manufacturers 2014-2020 11.2.3 Europe Paclitaxel Sales Price Assessment of Players 2014-2020 11.2.4 Europe Paclitaxel Sales Gross Margin Assessment of Players 2014-2020 11.2.5 Market Concentration 11.3 Asia-Pacific Market Performance for Manufacturers 11.3.1 Asia-Pacific Paclitaxel Sales Sales Assessment of Players 2014-2020 11.3.2 Asia-Pacific Paclitaxel Sales Revenue Assessment of Players 2014-2020 11.3.3 Asia-Pacific Paclitaxel Sales Price Assessment of Players 2014-2020 11.3.4 Asia-Pacific Paclitaxel Sales Gross Margin Assessment of Players 2014-2020 11.3.5 Market Concentration 11.4 South America Market Performance for Players 11.4.1 South America Paclitaxel Sales Sales Assessment of Players 2014-2020 11.4.2 South America Paclitaxel Sales Revenue Assessment of Players 2014-2020 11.4.3 South America Paclitaxel Sales Price Assessment of Players 2014-2020 11.4.4 South America Paclitaxel Sales Gross Margin Assessment of Players 2014-2020 11.4.5 Market Concentration 11.5 Middle East and Africa Market Performance for Players 11.5.1 Middle East and Africa Paclitaxel Sales Sales Assessment of Players 2014-2020 11.5.2 Middle East and Africa Paclitaxel Sales Revenue Assessment of Players 2014-2020 11.5.3 Middle East and Africa Paclitaxel Sales Price Assessment of Players 2014-2020 11.5.4 Middle East and Africa Paclitaxel Sales Gross Margin Assessment of Players 2014-2020 11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries 12.1 Asia Pacific 12.1.1 Asia Pacific Paclitaxel Sales Sales by Countries/Regions 2014-2020 12.1.2 Asia Pacific Paclitaxel Sales Revenue by Countries/Regions 2014-2020 12.1.3 Asia Pacific Paclitaxel Sales Average Price by Countries/Regions 2014-2020 12.2 North America 12.2.1 North America Paclitaxel Sales Sales by Countries/Regions 2014-2020 12.2.2 North America Paclitaxel Sales Revenue by Countries/Regions 2014-2020 12.2.3 North America Paclitaxel Sales Average Price by Countries/Regions 2014-2020 12.3 Europe 12.3.1 Europe Paclitaxel Sales Sales by Countries/Regions 2014-2020 12.3.2 Europe Paclitaxel Sales Revenue by Countries/Regions 2014-2020 12.3.3 Europe Paclitaxel Sales Average Price by Countries/Regions 2014-2020 12.4 South America 12.4.1 South America Paclitaxel Sales Sales by Countries/Regions 2014-2020 12.4.2 South America Paclitaxel Sales Revenue by Countries/Regions 2014-2020 12.4.3 South America Paclitaxel Sales Average Price by Countries/Regions 2014-2020 12.5 Middle East and Africa 12.5.1 Middle East and Africa Paclitaxel Sales Sales by Countries/Regions 2014-2020 12.5.2 Middle East and Africa Paclitaxel Sales Revenue by Countries/Regions 2014-2020 12.5.3 Middle East and Africa Paclitaxel Sales Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity 13.1 Technology 13.2 Market Opportunity
14 World Paclitaxel Sales Sales & Revenue Forecast 2021-2026 14.1 World Paclitaxel Sales Sales and Revenue Forecast by Regions 2021-2026 14.1.1 World Paclitaxel SalesSales and Market Share by Regions 14.1.2 World Paclitaxel SalesRevenue and Market Share by Regions
15 Asia Paclitaxel Sales Market Forecast 2021-2026 15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026 15.1.1 PaclitaxelReprocessor 15.1.2 PaclitaxelDrying & Storage Cabinets 15.1.3 PaclitaxelTransport Systems 15.1.4 Other Auxiliary Equipment 15.2 Consumption Forecast by Application, 2021-2026
16 North America Paclitaxel Sales Market Forecast 2021-2026 16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026 16.1.1 PaclitaxelReprocessor 16.1.2 PaclitaxelDrying & Storage Cabinets 16.1.3 PaclitaxelTransport Systems 16.1.4 Other Auxiliary Equipment 16.2 Consumption Forecast by Application, 2021-2026
17 Europe Paclitaxel Sales Market Forecast 2021-2026 17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026 17.1.1 PaclitaxelReprocessor 17.1.2 PaclitaxelDrying & Storage Cabinets 17.1.3 PaclitaxelTransport Systems 17.1.4 Other Auxiliary Equipment 17.2 Consumption Forecast by Application, 2021-2026
18 South America Paclitaxel Sales Market Forecast 2021-2026 18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026 18.1.1 Paclitaxel Reprocessor 18.1.2 Paclitaxel Drying & Storage Cabinets 18.1.3 Paclitaxel Transport Systems 18.1.4 Other Auxiliary Equipment 18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Paclitaxel Sales Market Forecast 2021-2026 19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026 19.1.1 Paclitaxel Reprocessor 19.1.2 Paclitaxel Drying & Storage Cabinets 19.1.3 Paclitaxel Transport Systems 19.1.4 Other Auxiliary Equipment 19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast 20.1 Global Paclitaxel Sales Price (USD/Unit) Trend 2021-2026 20.2 Global Paclitaxel Sales Gross Profit Trend 2021-2026